Protocols
GIAJCAP
Adjuvant Therapy of Colon Cancer Using Capecitabine
GIAJCAPOX
Adjuvant Combination Chemotherapy for Stage III and Stage IIB Colon Cancer Using Oxaliplatin and Capecitabine
GIAJFFOX
Adjuvant Combination Chemotherapy for Stage III and Stage IIB Colon Cancer Using Oxaliplatin, Fluorouracil and Leucovorin
GIAJFL
Adjuvant Therapy of Colon Cancer Using Fluorouracil Injection and Infusion and Leucovorin Infusion
GIAJRALOX
Adjuvant Combination Chemotherapy for Node Positive Colon Cancer Using Oxaliplatin and Raltitrexed in Patients Intolerant to Fluorouracil or Capecitabine
GIRAJCOX
Adjuvant Combination Chemotherapy for Stage III Rectal Cancer Using Oxaliplatin and Capecitabine
GIRAJFFOX
Adjuvant Combination Chemotherapy for Stage III Rectal Cancer Using Oxaliplatin, Fluorouracil and Leucovorin
GIRCAP
Adjuvant Therapy for Stage II and III Rectal Cancer Previously Treated with Preoperative Radiation Therapy using Capecitabine
GIRCRT
Combined Modality Adjuvant Therapy for High Risk Rectal Carcinoma Using Capecitabine and Radiation Therapy
GIRINFRT
Combined Modality Adjuvant Therapy for High Risk Rectal Carcinoma Using Capecitabine, Infusional Fluorouracil and Radiation Therapy
GIAVCAP
Palliative Therapy of Advanced Colorectal Cancer using Capecitabine
GIAVCAPB
Palliative Therapy of Advanced Colorectal Cancer using Capecitabine and Bevacizumab
GIAVCETIR
Third Line Treatment of Metastatic Colorectal Cancer Using Cetuximab in Combination with Irinotecan
GIAVCRT
Combined Modality Therapy for Metastatic Rectal Carcinoma using Capecitabine and Radiation Therapy
GIAVFL
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Fluorouracil Injection and Infusion and Leucovorin Infusion
UGIAVPANEN
Treatment of BRAF V600E - Mutated Metastatic Colorectal Cancer using PANitumumab and Encorafenib
GIAVPANI
Palliative Third Line Treatment of Metastatic Colorectal Cancer Using Panitumumab
UGIAVPEM
First-Line Treatment of dMMR/MSI-H Metastatic Colorectal Cancer using Pembrolizumab
UGIAVPEM6
First-Line Treatment of dMMR/MSI-H Metastatic Colorectal Cancer using 6-Weekly Pembrolizumab
GIAVRALIR
Palliative Therapy of Metastatic Colorectal Cancer using Irinotecan and Raltitrexed in Patients Intolerant to Fluorouracil or Capecitabine
GIAVRALOX
Palliative Therapy of Metastatic Colorectal Cancer using Oxaliplatin and Raltitrexed in Patients Intolerant to Fluorouracil or Capecitabine
GIAVTTB
Therapy of Advanced Colorectal Cancer using Trifluridine-Tipiracil and Bevacizumab
GICAPIRI
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan and Capecitabine in Patients Unsuitable for GIFOLFIRI
GICAPOX
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin and Capecitabine
GICIRB
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Bevacizumab and Capecitabine
GICOXB
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Bevacizumab and Capecitabine
GIFFIRB
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Fluorouracil, Leucovorin and Bevacizumab
GIFFIRPAN
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Fluorouracil, Leucovorin, and PANitumumab
GIFFOXB
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil, Leucovorin and Bevacizumab
GIFFOXPAN
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil, Leucovorin, and PANitumumab
GIFOLFIRI
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Fluorouracil and Leucovorin
GIFOLFOX
Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil and Leucovorin
GIIR
Palliative Chemotherapy of Metastatic Colorectal Cancer Using Irinotecan
GIIRINALT
Palliative Chemotherapy of Metastatic Colorectal Cancer Using Weekly Irinotecan
GIRALT
Palliative Chemotherapy for Metastatic Colorectal Cancer using Raltitrexed in Patients with Previous Fluorouracil Toxicity
GIAJNIV
Adjuvant Treatment of Resected Esophageal or Gastroesophageal Junction Cancer using Nivolumab
GIAVDOC
Palliative Treatment of Metastatic Esophagogastric Adenocarcinoma with DOCEtaxel
GIEFFOXRT
Combined Modality Therapy for Locally Advanced Esophageal Cancer using Oxaliplatin, Fluorouracil, Leucovorin, and Radiation Therapy
GIENACTRT
Neoadjuvant Treatment of Esophageal and Gastroesophageal Carcinomas Using CARBOplatin, PACLitaxel and Radiation Therapy
GIFUC
Palliative Chemotherapy for Upper Gastrointestinal Tract Cancer (Gastric, Esophageal, Gall Bladder Carcinoma and Cholangiocarcinoma) and Metastatic Anal Cancer Using Infusional Fluorouracil and CISplatin
GIGAJCOX
Adjuvant Chemotherapy in Gastric Cancer Patients with D2 Resection (Node Negative) or Ineligible for Adjuvant Chemoradiation Using Oxaliplatin and Capecitabine
GIGAJCPRT
Adjuvant Chemotherapy of Gastric Cancer Patients with Completely Resected Gastric Cancer Using CISplatin and Capecitabine and Radiation Therapy
GIGAJFFOX
Adjuvant Chemotherapy of Gastric Cancer Patients with D2 Resection (Node Negative) or Ineligible for Adjuvant Chemoradiation Using Oxaliplatin, Fluorouracil, and Leucovorin
GIGAVCCT
Palliative Treatment of Metastatic or Locally Advanced Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Using CISplatin, Capecitabine and Trastuzumab
GIGAVCFT
Palliative Treatment of Metastatic or Inoperable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma using CISplatin, Infusional Fluorouracil and Trastuzumab
Advanced Gastric, Gastroesophageal Junction or Esophageal Carcinoma using Capecitabine and Oxaliplatin
First-Line Treatment of Locally Advanced or Metastatic Esophageal, Gastroesophageal, or Gastric Cancer using Oxaliplatin, Capecitabine and Nivolumab
First-Line Treatment of Locally Advanced or Metastatic Gastroesophageal Cancer using Oxaliplatin, Capecitabine and Pembrolizumab
Palliative Treatment of Metastatic or Locally Advanced Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Using Capecitabine, Oxaliplatin, and Trastuzumab
Palliative Treatment of Metastatic or Locally Advanced Gastric, Gastroesophageal Junction or Esophageal Carcinoma using Oxaliplatin, Fluorouracil and Leucovorin
First-Line Treatment of Locally Advanced or Metastatic Esophageal, Gastroesophageal, or Gastric Cancer using Oxaliplatin, Fluorouracil, Leucovorin and Nivolumab
First-Line Treatment of Locally Advanced or Metastatic Gastroesophageal Cancer using Oxaliplatin, Fluorouracil, Leucovorin and Pembrolizumab
Palliative Treatment of Metastatic or Locally Advanced HER-2 Positive Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Using Oxaliplatin, Fluorouracil, Leucovorin, and Trastuzumab
Treatment of Advanced Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma using Pembrolizumab, Capecitabine, Oxaliplatin, and Trastuzumab
Treatment of Advanced Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma using Pembrolizumab, Oxaliplatin, Fluorouracil, Leucovorin, and Trastuzumab
GIGAVRAMT
Second-Line Therapy for Metastatic or Locally Advanced Gastric or Gastroesophageal Junction Cancer Using Weekly PACLitaxel and Ramucirumab
GIGAVTR
Continuation of Palliative Treatment of Metastatic or Inoperable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma using Trastuzumab
GIGAVTT (previously GIGAVTRFT)
Third- or Later-Line Therapy of Advanced Gastroesophageal Carcinoma using Trifluridine-Tipiracil
GIGECC
Perioperative Treatment of Resectable Adenocarcinoma of the Stomach, Gastroesophageal Junction or Lower 1/3 Esophagus Using Epirubicin, CISplatin and Capecitabine
GIGFLODOC
Perioperative Treatment of Resectable Adenocarcinoma of the Stomach, Gastroesophageal Junction or Lower 1/3 Esophagus using DOCEtaxel, Oxaliplatin, Infusional Fluorouracil, and Leucovorin
GIGFOLFIRI
Second Line Palliative Combination Chemotherapy for Metastatic Gastric or Esophageal Adenocarcinoma Using Irinotecan, Fluorouracil and Leucovorin
GIAVDUR4
Treatment of Advanced Biliary Tract Cancer using Durvalumab
GIAVDURPG
First-line Palliative Treatment of Advanced Biliary Tract Cancer using Durvalumab, Gemcitabine and Platinum
GIAVPG
First-line Palliative Chemotherapy for Advanced Gallbladder, Pancreatic Carcinoma, and Cholangiocarcinoma using Gemcitabine and CISplatin
GIBAJCAP
Adjuvant Therapy of Biliary Cancer using Capecitabine
GIBYTT
Yttrium-90 for Transarterial Radioembolization (TARE) for Locally Advanced Cholangiocarcinoma or Gallbladder Carcinoma Not Amenable for Surgical Resection
GIFIRINOX
Palliative Combination Chemotherapy for Advanced Pancreatic Adenocarcinoma Using Irinotecan, Oxaliplatin, Fluorouracil and Leucovorin
GIFUC
(See under
Esophagus, Stomach Section)
GIPAJFIROX
Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma Using Irinotecan, Oxaliplatin, Fluorouracil and Leucovorin
GIPAJGCAP
Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma Using Capecitabine and Gemcitabine
GIPAJGEM
Adjuvant Chemotherapy for Pancreatic Adenocarcinoma Using Gemcitabine
GIPAVCAP (deleted 01 Jul 2024)
Second line Treatment of Metastatic or Unresectable Pancreatic Adenocarcinoma Using Capecitabine
ONLY use GIPAVCAP to complete treatment with existing patients. Use GIAVCAP for new patients
GIPAVFFIRI
Second Line Treatment for Metastatic Pancreatic Cancer Using Irinotecan, Fluorouracil and Leucovorin
GIPAVFFOX
Palliative Combination Chemotherapy for Metastatic Pancreatic Cancer Using Oxaliplatin, Fluorouracil, and Leucovorin
GIPGEM
Palliative Therapy for Pancreatic Adenocarcinoma, Gallbladder Cancer, and Cholangiocarcinoma Using Gemcitabine
GIPGEMABR
First Line Treatment of Locally Advanced and Metastatic Pancreatic Cancer with PACLitaxel NAB (ABRAXANE) and Gemcitabine
GIA
Palliative Therapy for Hepatoma Using DOXOrubicin
GIATZB
First-Line Treatment of Advanced Hepatocellular Carcinoma using Atezolizumab and Bevacizumab
UGICABO
Treatment of Advanced Hepatocellular Carcinoma using Cabozantinib
GIDEBTACE
Transarterial Chemoembolization (TACE) of Hepatocellular Carcinoma Using Drug-Eluting Bead (DEB) Loaded with DOXOrubicin
GILEN
First Line Therapy of Advanced Hepatocellular Carcinoma Using Lenvatinib
GIREGO
Treatment of Advanced Hepatocellular Carcinoma Using Regorafenib
GISORAF
Therapy for Advanced Hepatocellular Carcinoma Using SORAfenib
GITREMDUR
First-Line Treatment of Advanced Hepatocellular Carcinoma using Tremelimumab and Durvalumab
UGIYTT
Yttrium-90 for Transarterial Radioembolization (TARE) for Hepatocellular Cancer or Neuroendocrine Tumours with Hepatic Disease
GIAVTZCAP
Palliative Therapy of Metastatic Neuroendocrine Cancer Using Temozolomide and Capecitabine
GIENDO2
Palliative Therapy for Pancreatic Endocrine Tumours Using Streptozocin and DOXOrubicin
Symptomatic Management of Functional Carcinoid and Neuroendocrine Tumours of the GI Tract Using Lanreotide (SOMATULINE AUTOGEL®)
Treatment of Advanced Neuroendocrine Tumours of Gastrointestinal Origin (Non-Functional) Using Everolimus
Management of Non-Functional Neuroendocrine Tumours of the GI Tract Using Octreotide (SANDOSTATIN LAR)
GINPRRT
Out-of-Province Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumours
GIOCTLAR
Symptomatic Management of Functional Carcinoid and Neuroendocrine Tumours of the GI Tract Using Octreotide
GIPE
Palliative Therapy of Neuroendocrine Tumours Using CISplatin and Etoposide
GIPNEVER
Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using Everolimus
GIPNSUNI
Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours Using SUNItinib
UGIPRRT
Peptide Receptor Radionuclide Therapy (PRRT) using Lutetium 177Lu-Dotatate (LUTATHERA) for Treatment in Patients with Somatostatin Receptor Positive Neuroendocrine Tumours
GIAAVCT
First-Line Palliative Treatment of Metastatic Anal Squamous Cell Carcinoma Using CARBOplatin and Weekly PACLitaxel
GICART
Combined Modality Therapy for Carcinoma of the Anal Canal Using Mitomycin, Capecitabine and Radiation Therapy
GICPART
Combined Modality Therapy for Carcinoma of the Anal Canal Using CISplatin, Capecitabine and Radiation Therapy
GIFUART
Combined Modality Curative Therapy for Carcinoma of the Anal Canal Using Mitomycin, Fluorouracil and Radiation Therapy
Combined Modality Curative Therapy for Carcinoma of the Anal Canal Using CISplatin, Infusional Fluorouracil and Radiation Therapy
(SEE UNDER ESOPHAGUS, STOMACH SECTION)
GIFUIP
Chemotherapy of Pseudomyxoma Peritonei Using Intraperitoneal Mitomycin and Fluorouracil
GIGAVCC
Palliative Therapy of Metastatic or Locally Advanced Anal Squamous Cell Carcinoma using CISplatin and Capecitabine
GIHIPEC
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Carcinomatosis from Limited Advanced Colorectal and Appendiceal Carcinomas Using Oxaliplatin and Fluorouracil (5-FU)
GIPMHIPEC
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Mesothelioma Using Doxorubicin, Cisplatin and Paclitaxel
